Zimmer Biomet (ZBH) PT Raised to $150 at BMO Capital
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $99.57 +1.72%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
BMO Capital analyst Joanne Wuensch raised the price target on Zimmer Biomet (NYSE: ZBH) to $150.00 (from $137.00) while maintaining an Outperform rating.
- On the Recovery Road, Six Months Ahead of Schedule
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Legence Corp (LGN) PT Lowered to $100 at BTIG
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
